首页> 美国卫生研究院文献>Antimicrobial Resistance and Infection Control >Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control
【2h】

Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control

机译:预防耐碳青霉烯的肠杆菌科细菌进入医疗机构的感染预防和控制措施及工具:欧洲疾病预防与控制中心的指导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInfections with carbapenem-resistant Enterobacteriaceae (CRE) are increasingly being reported from patients in healthcare settings. They are associated with high patient morbidity, attributable mortality and hospital costs. Patients who are “at-risk” may be carriers of these multidrug-resistant Enterobacteriaceae (MDR-E).The purpose of this guidance is to raise awareness and identify the “at-risk” patient when admitted to a healthcare setting and to outline effective infection prevention and control measures to halt the entry and spread of CRE.
机译:背景技术在医疗机构中,越来越多的患者报道了对碳青霉烯类耐药的肠杆菌科(CRE)的感染。它们与高患者发病率,可归因的死亡率和医院费用有关。 “高危”患者可能是这些多药耐药性肠杆菌科(MDR-E)的携带者。本指南的目的是提高人们的认识,并在进入医疗机构时识别“高危”患者,并概述有效的感染预防和控制措施,以阻止CRE的进入和传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号